Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,148
datasets available to search
ShareScore release 0.9.0
Dataset results
2,148 results for “HER2”
Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer
ClinicalTrials.gov study NCT05113251. IPD Sharing: YES. Countries: 18. Publications: 0.
Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer
ClinicalTrials.gov study NCT04504331. IPD Sharing: NO. Countries: 1. Publications: 0.
Carboplatin, Abraxane, Avastin as Neoadjuvant Therapy for Her2-Negative Breast Cancer
ClinicalTrials.gov study NCT00723125. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Composite Assay for HER2-positive Early-stage Breast Cancer Management
ClinicalTrials.gov study NCT06762977. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study Evaluating the Safety and Efficacy of Venetoclax in Combination With Trastuzumab Emtansine in Patients With Previously Treated HER2-Positive Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT04298918. IPD Sharing: YES. Countries: 2. Publications: 0.
Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients
ClinicalTrials.gov study NCT02297698. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer
ClinicalTrials.gov study NCT02586675. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer
ClinicalTrials.gov study NCT01730833. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer
ClinicalTrials.gov study NCT00821886. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HER2-positive Breast Cancer Project Initiated by Investigators
ClinicalTrials.gov study NCT05346328. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Study of Human Epidermal Growth Receptor (HER2) Status Evaluation in Breast Cancer Pathology Samples
ClinicalTrials.gov study NCT02580799. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Maintenance Treatment (Trastuzumab and Pertuzumab) After Initial Chemotherapy in a Phase Ib/II Trial for Advanced HER2 Positive Br
ClinicalTrials.gov study NCT04108858. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer
ClinicalTrials.gov study NCT01132664. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors
ClinicalTrials.gov study NCT04450732. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
ClinicalTrials.gov study NCT06369285. IPD Sharing: YES. Countries: 3. Publications: 0.
Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Loc
ClinicalTrials.gov study NCT00696072. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Avastin (Bevacizumab) and Sequential Chemotherapy in Patients With Primary HER2 Negative Operable Breast Cancer.
ClinicalTrials.gov study NCT00559754. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Therapy With MYOCET® (Doxorubicin HCL Liposome for Injection) in Participants With HER2-Positive Breast Cancer
ClinicalTrials.gov study NCT00712881. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Comparison of Efficacy and Frequency of Adverse Events of 1st Line Palliative Chemotherapy EOX and mDCF Regimens in Advanced HER2-negative Gastric Carcinoma
ClinicalTrials.gov study NCT02445209. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Testing Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol Q)
ClinicalTrials.gov study NCT04439110. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.